Literature DB >> 31326473

Natural History of Myocardial Late Gadolinium Enhancement Predicts Adverse Clinical Events in Heart Transplant Recipients.

Kongkiat Chaikriangkrai, Muhannad Aboud Abbasi, Roberto Sarnari, Daniel Lee, Allen S Anderson, Kambiz Ghafourian, Sadiya S Khan, Esther E Vorovich, Jonathan D Rich, Jane E Wilcox, Julie A Blaisdell, Clyde W Yancy, James Carr, Michael Markl.   

Abstract

Entities:  

Year:  2019        PMID： 31326473      PMCID： PMC7003669          DOI： 10.1016/j.jcmg.2019.05.014

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


× No keyword cloud information.
  4 in total

1.  Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension.

Authors:  Kevin G Blyth; Bjoern A Groenning; Thomas N Martin; John E Foster; Patrick B Mark; Henry J Dargie; Andrew J Peacock
Journal:  Eur Heart J       Date:  2005-05-17       Impact factor: 29.983

2.  Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes.

Authors:  Craig R Butler; Andreas Kumar; Mustafa Toma; Richard Thompson; Kelvin Chow; Debra Isaac; Daniel Kim; Mark Haykowsky; Matthias G Friedrich; Ian Paterson
Journal:  Can J Cardiol       Date:  2013-02-04       Impact factor: 5.223

3.  Cardiovascular MRI predicts 5-year adverse clinical outcome in heart transplant recipients.

Authors:  C R Butler; D H Kim; K Chow; M Toma; R Thompson; M Mengel; M Haykowsky; G J Pearson; I Paterson
Journal:  Am J Transplant       Date:  2014-08-06       Impact factor: 8.086

4.  Prognostic impact of late gadolinium enhancement in the risk stratification of heart transplant patients.

Authors:  Patrizia Pedrotti; Claudia Vittori; Rita Facchetti; Stefano Pedretti; Santo Dellegrottaglie; Angela Milazzo; Maria Frigerio; Manlio Cipriani; Cristina Giannattasio; Alberto Roghi; Ornella Rimoldi
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2016-09-13       Impact factor: 6.875
  4 in total
  3 in total

Review 1.  The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences.

Authors:  C Sciaccaluga; N Ghionzoli; G E Mandoli; N Sisti; F D'Ascenzi; M Focardi; S Bernazzali; G Vergaro; M Emdin; S Valente; M Cameli
Journal:  Heart Fail Rev       Date:  2021-08-12       Impact factor: 4.654

2.  Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy.

Authors:  Nazia Husain; Kae Watanabe; Haben Berhane; Aditi Gupta; Michael Markl; Cynthia K Rigsby; Joshua D Robinson
Journal:  J Cardiovasc Magn Reson       Date:  2021-11-22       Impact factor: 5.364

3.  Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients.

Authors:  Kongkiat Chaikriangkrai; Muhannad Aboud Abbasi; Roberto Sarnari; Ryan Dolan; Daniel Lee; Allen S Anderson; Kambiz Ghafourian; Sadiya S Khan; Esther E Vorovich; Jonathan D Rich; Jane E Wilcox; Julie A Blaisdell; Clyde W Yancy; James Carr; Michael Markl
Journal:  JACC Cardiovasc Imaging       Date:  2020-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.